These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 19996936
21. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC. Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781 [Abstract] [Full Text] [Related]
22. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L. J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114 [Abstract] [Full Text] [Related]
23. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB. AIDS; 2001 Oct 19; 15(15):1951-7. PubMed ID: 11600822 [Abstract] [Full Text] [Related]
24. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. Flys TS, McConnell MS, Matovu F, Church JD, Bagenda D, Khaki L, Bakaki P, Thigpen MC, Eure C, Fowler MG, Eshleman SH. J Infect Dis; 2008 Aug 15; 198(4):465-9. PubMed ID: 18582198 [Abstract] [Full Text] [Related]
30. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB. AIDS Res Hum Retroviruses; 2004 Jun 15; 20(6):595-9. PubMed ID: 15242535 [Abstract] [Full Text] [Related]
31. Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission. Hauser A, Sewangi J, Mbezi P, Dugange F, Lau I, Ziske J, Theuring S, Kuecherer C, Harms G, Kunz A. PLoS One; 2012 Jun 15; 7(2):e32055. PubMed ID: 22384138 [Abstract] [Full Text] [Related]